Certified by Founder Lodge
Octave (US)
United States - Menlo Park, California
START UP
1 Disclosed Funding Rounds $30,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Octave’s Precision Care Solution is the first-of-its-kind that accurately and objectively measures, and helps manage, complex and high-cost neurodegenerative diseases, starting with multiple
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 27 ,2023 | Series B | $30,000,000 | |
| November, 16 ,2023 | Unknown | $10,000,000.00 |
Intermountain Ventures
Casdin Capital, LLC
Northpond Ventures
S32
Deerfield Management
Echo Health Ventures
Hikma Ventures
The Blue Venture Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
